These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
654 related articles for article (PubMed ID: 14754411)
1. Reversing agents for ATP-binding cassette (ABC) transporters: application in modulating multidrug resistance (MDR). Lee CH Curr Med Chem Anticancer Agents; 2004 Jan; 4(1):43-52. PubMed ID: 14754411 [TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance: molecular mechanisms and clinical relevance. Ling V Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126 [TBL] [Abstract][Full Text] [Related]
3. Reversing agents for ATP-binding cassette drug transporters. Lee CH Methods Mol Biol; 2010; 596():325-40. PubMed ID: 19949930 [TBL] [Abstract][Full Text] [Related]
4. Lapatinib (Tykerb, GW572016) reverses multidrug resistance in cancer cells by inhibiting the activity of ATP-binding cassette subfamily B member 1 and G member 2. Dai CL; Tiwari AK; Wu CP; Su XD; Wang SR; Liu DG; Ashby CR; Huang Y; Robey RW; Liang YJ; Chen LM; Shi CJ; Ambudkar SV; Chen ZS; Fu LW Cancer Res; 2008 Oct; 68(19):7905-14. PubMed ID: 18829547 [TBL] [Abstract][Full Text] [Related]
5. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells. Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350 [TBL] [Abstract][Full Text] [Related]
6. β-carotene reverses multidrug resistant cancer cells by selectively modulating human P-glycoprotein function. Teng YN; Sheu MJ; Hsieh YW; Wang RY; Chiang YC; Hung CC Phytomedicine; 2016 Mar; 23(3):316-23. PubMed ID: 26969385 [TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. Pérez-Tomás R Curr Med Chem; 2006; 13(16):1859-76. PubMed ID: 16842198 [TBL] [Abstract][Full Text] [Related]
8. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR). Teodori E; Dei S; Martelli C; Scapecchi S Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921 [TBL] [Abstract][Full Text] [Related]
9. 9-Deazapurines as Broad-Spectrum Inhibitors of the ABC Transport Proteins P-Glycoprotein, Multidrug Resistance-Associated Protein 1, and Breast Cancer Resistance Protein. Stefan K; Schmitt SM; Wiese M J Med Chem; 2017 Nov; 60(21):8758-8780. PubMed ID: 29016119 [TBL] [Abstract][Full Text] [Related]
10. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes. To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522 [TBL] [Abstract][Full Text] [Related]
11. Parguerenes: Marine red alga bromoditerpenes as inhibitors of P-glycoprotein (ABCB1) in multidrug resistant human cancer cells. Huang XC; Sun YL; Salim AA; Chen ZS; Capon RJ Biochem Pharmacol; 2013 May; 85(9):1257-68. PubMed ID: 23415901 [TBL] [Abstract][Full Text] [Related]
12. Development of Fourth Generation ABC Inhibitors from Natural Products: A Novel Approach to Overcome Cancer Multidrug Resistance. Karthikeyan S; Hoti SL Anticancer Agents Med Chem; 2015; 15(5):605-15. PubMed ID: 25584696 [TBL] [Abstract][Full Text] [Related]
13. Understanding of human ATP binding cassette superfamily and novel multidrug resistance modulators to overcome MDR. Mohammad IS; He W; Yin L Biomed Pharmacother; 2018 Apr; 100():335-348. PubMed ID: 29453043 [TBL] [Abstract][Full Text] [Related]
15. Relevance of multidrug resistance in the age of targeted therapy. Türk D; Szakács G Curr Opin Drug Discov Devel; 2009 Mar; 12(2):246-52. PubMed ID: 19333870 [TBL] [Abstract][Full Text] [Related]
16. Marine Natural Products as Models to Circumvent Multidrug Resistance. Long S; Sousa E; Kijjoa A; Pinto MM Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665 [TBL] [Abstract][Full Text] [Related]
17. Effect of β-elemene on the kinetics of intracellular transport of d-luciferin potassium salt (ABC substrate) in doxorubicin-resistant breast cancer cells and the associated molecular mechanism. Tang CY; Zhu LX; Yu JD; Chen Z; Gu MC; Mu CF; Liu Q; Xiong Y Eur J Pharm Sci; 2018 Jul; 120():20-29. PubMed ID: 29704644 [TBL] [Abstract][Full Text] [Related]
18. Overcoming ABC transporter-mediated multidrug resistance: Molecular mechanisms and novel therapeutic drug strategies. Li W; Zhang H; Assaraf YG; Zhao K; Xu X; Xie J; Yang DH; Chen ZS Drug Resist Updat; 2016 Jul; 27():14-29. PubMed ID: 27449595 [TBL] [Abstract][Full Text] [Related]
19. The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer. Wang Y; Wang Y; Qin Z; Cai S; Yu L; Hu H; Zeng S Expert Opin Drug Metab Toxicol; 2021 Mar; 17(3):291-306. PubMed ID: 33544643 [TBL] [Abstract][Full Text] [Related]
20. Resveratrol-mediated reversal of tumor multi-drug resistance. Hu Y; Li C; Li H; Li M; Shu X Curr Drug Metab; 2014; 15(7):703-10. PubMed ID: 25255872 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]